TriSalus Life Sciences (NASDAQ:TLSI) Coverage Initiated by Analysts at Canaccord Genuity Group
Canaccord Genuity Group initiated coverage on shares of TriSalus Life Sciences (NASDAQ:TLSI – Free Report) in a report published on Thursday morning, Marketbeat.com reports. The firm issued a buy rating and a $12.00 target price on the stock. Separately, Jonestrading began coverage on shares of TriSalus Life Sciences in a report on Friday, May 10th. […]
More Stories
Disney to Pay $10 Million to Resolve Children’s Privacy Claims
By Bill Pan Disney will pay $10 million to settle allegations that it violated a federal children’s privacy law through...
Federal Reserve Minutes Reflect Ongoing Divergence Over Interest Rates
By Andrew Moran The Federal Reserve’s December meeting proved far more fractured than the final vote suggested, underscoring the persistent...
US, Allied Forces Have Killed or Captured More Than 2 Dozen ISIS Operatives in Syria
By Jacob Burg The United States and its partner forces have captured or killed nearly 25 operatives of the ISIS...
Beijing Invokes ‘Make America Great Again’ in Rare Bid to Ease US Tensions
By Michael Zhuang From Dec. 26 to 29, Chinese state media published a rare series of editorials striking a conciliatory...
Judge Blocks White House’s Attempt to Defund Consumer Watchdog Agency
By Jack Phillips A federal judge ruled Tuesday that the White House cannot lapse its funding of the Consumer Financial...
Top 11 Hottest News Anchors in the World of All Time
News anchors have become a part of global personality. They are no longer just people who read headlines. Now, viewers...